Gallen conference, Ki-67 level became the standard factor for differentiating between luminal B and luminal A types in patients with estrogen receptor-positive (ER +) and HER2-negative (HER2-) breast cancer; the recommended cutoff value for this classification was 14% [6]. The gene discussed is ERBB2; the disease is breast carcinoma.